## to medications and development of future therapies. Subsequently top

executives at GSK became leaders in global health issues. Andrew Witty

assumed the CEO position at GlaxoSmithKline in 2008 and became one

Copyright Â© 2019 Harvard Business School Publishing. All rights reserved.

2

This document is authorized for use only by Matt O'Donnell (matthew.od11@gmail.com). Copying or posting is an infringement of copyright. Please contact customerservice@harvardbusiness.org or 800-988-0886 for additional copies.